Literature DB >> 23803229

Success rates of endoscopic-assisted probing for congenital nasolacrimal duct obstruction in children.

S Theodoropoulou1, M S M Sutherland, K Haddow, A Blaikie.   

Abstract

OBJECTIVE: To determine the success rate of initial probing in children with congenital nasolacrimal duct obstruction at different ages, using nasal endoscopy.
METHODS: Fifty eyes of 38 consecutive children with congenital nasolacrimal duct obstruction underwent endoscopic nasolacrimal duct probing under general anaesthesia. Patients were followed up for at least three months. Probing success was defined as complete remission of symptoms and a normal fluorescein dye disappearance test result.
RESULTS: The age range of patients was 17-109 months. The success rates of probing were: 100 per cent (29 out of 29) for cases of stenosis at the lower nasolacrimal duct, 100 per cent (7 out of 7) for functional epiphora cases and 92.86 per cent (13 out of 14) for nasolacrimal atresia cases. Overall, there was only one child for whom the probing treatment for nasolacrimal duct obstruction was not successful; this child had Down's syndrome and a more complex developmental abnormality of the nasolacrimal duct. Age and site of obstruction were not found to significantly affect the outcome of probing.
CONCLUSION: Probing of the nasolacrimal system using an endoscopic approach allows direct visualisation of the nasolacrimal duct. This can facilitate diagnosis of the anomaly and significantly increase the procedure success rate.

Entities:  

Mesh:

Year:  2013        PMID: 23803229     DOI: 10.1017/S0022215113001370

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  8 in total

1.  Success rates of dacryoendoscopy-guided probing for recalcitrant congenital nasolacrimal duct obstruction.

Authors:  Masahiro Fujimoto; Ken Ogino; Hiroko Matsuyama; Chika Miyazaki
Journal:  Jpn J Ophthalmol       Date:  2016-04-27       Impact factor: 2.447

2.  Effects of medication methods after simple and effective probing of lacrimal passage.

Authors:  Bin Lu; Hua-Ying Xie; Cai-Ping Shi; Chun-Si Xu; Mei-Hong Gu
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

3.  Transcanalicular endoscopic primary dacryoplasty for congenital nasolacrimal duct obstruction.

Authors:  Nozomi Matsumura; Toru Suzuki; Satoshi Goto; Takeshi Fujita; Shin Yamane; Maiko Maruyama-Inoue; Kazuaki Kadonosono
Journal:  Eye (Lond)       Date:  2019-02-19       Impact factor: 3.775

4.  Nasal endoscopic features and outcomes of nasal endoscopy guided bicanalicular intubation for complex persistent congenital nasolacrimal duct obstructions.

Authors:  Manpreet Singh; Manjula Sharma; Manpreet Kaur; Aditi Mehta Grewal; Deepti Yadav; Sabia Handa; Sonam Yangzes; Zoramthara Zadeng; Pankaj Gupta
Journal:  Indian J Ophthalmol       Date:  2019-07       Impact factor: 1.848

5.  Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.

Authors:  Rui Shi; Pei-Yin Wang; Xin-Yi Li; Jian-Xin Chen; Yan Li; Xin-Zhong Zhang; Chen-Guang Zhang; Tao Jiang; Wen-Bin Li; Wei Ding; Shu-Jun Cheng
Journal:  Oncotarget       Date:  2015-09-29

6.  Nasal endoscopy in the management of congenital nasolacrimal duct obstruction.

Authors:  Yasser H Al-Faky
Journal:  Saudi J Ophthalmol       Date:  2013-11-13

Review 7.  Insights in the treatment of congenital nasolacrimal duct obstruction.

Authors:  Elena Avram
Journal:  Rom J Ophthalmol       Date:  2017 Apr-Jun

Review 8.  Congenital Nasolacrimal Duct Obstruction (CNLDO): A Review.

Authors:  Aldo Vagge; Lorenzo Ferro Desideri; Paolo Nucci; Massimiliano Serafino; Giuseppe Giannaccare; Andrea Lembo; Carlo Enrico Traverso
Journal:  Diseases       Date:  2018-10-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.